Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) – Stock analysts at Wedbush dropped their Q1 2024 earnings estimates for shares of Sage Therapeutics in a research note issued on Wednesday, April 17th. Wedbush analyst L. Chico now expects that the biopharmaceutical company will post earnings of ($1.92) per share for the quarter, down from their […]
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its target price lowered by equities researchers at TD Cowen from $30.00 to $16.00 in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. TD Cowen’s target price would suggest a potential upside of […]
Sage Therapeutics (NASDAQ:SAGE) Hits New 12-Month Low at $15 06 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Sage Therapeutics (NASDAQ:SAGE – Free Report) had its price objective upped by JPMorgan Chase & Co. from $24.00 to $29.00 in a report issued on Tuesday, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. Several other analysts have also recently weighed in on SAGE. Stifel Nicolaus reduced their price target […]
Sage Therapeutics (NASDAQ:SAGE) Shares Gap Up Following Analyst Upgrade themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.